Literature DB >> 16377187

Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines.

Xiaohu Ouyang1, Evgueni L Piatnitski, Vatee Pattaropong, Xiaoling Chen, Hai-Ying He, Alexander S Kiselyov, Avdhoot Velankar, Joel Kawakami, Marc Labelle, Leon Smith, Julia Lohman, Sui Ping Lee, Asra Malikzay, James Fleming, Jason Gerlak, Ying Wang, Robin L Rosler, Kai Zhou, Stan Mitelman, Margarita Camara, David Surguladze, Jacqueline F Doody, M Carolina Tuma.   

Abstract

Oxadiazole derivatives were synthesized and evaluated for their ability to inhibit tubulin polymerization and to cause mitotic arrest in tumor cells. The most potent compounds inhibited tubulin polymerization at concentrations below 1 microM. Lead analogs caused mitotic arrest of A431 human epidermoid cells and cells derived from multi-drug resistant tumors (10, EC(50)=7.8 nM). Competition for the colchicine binding site and pharmacokinetic properties of selected potent compounds were also investigated and are reported herein, along with structure-activity relationships for this novel series of antimitotic agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16377187     DOI: 10.1016/j.bmcl.2005.11.094

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy.

Authors:  Eugene L Piatnitski Chekler; Alexander S Kiselyov; Xiaohu Ouyang; Xiaoling Chen; Vatee Pattaropong; Ying Wang; M Carolina Tuma; Jacqueline F Doody
Journal:  ACS Med Chem Lett       Date:  2010-08-20       Impact factor: 4.345

2.  Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor.

Authors:  Maria Carolina Tuma; Asra Malikzay; Xiaohu Ouyang; David Surguladze; James Fleming; Stan Mitelman; Margarita Camara; Bridget Finnerty; Jacqueline Doody; Eugene L P Chekler; Paul Kussie; James R Tonra
Journal:  Transl Oncol       Date:  2010-10-01       Impact factor: 4.243

3.  Synthesis and cytotoxic evaluation of some quinazolinone- 5-(4-chlorophenyl) 1, 3, 4-oxadiazole conjugates.

Authors:  Farshid Hassanzadeh; Hojjat Sadeghi-Aliabadi; Elham Jafari; Azadeh Sharifzadeh; Nasim Dana
Journal:  Res Pharm Sci       Date:  2019-10-04

4.  Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs.

Authors:  Bhaskar C Das; Xiang-Ying Tang; Patrick Rogler; Todd Evans
Journal:  Tetrahedron Lett       Date:  2012-08-01       Impact factor: 2.415

5.  Copper-Catalyzed One-Pot Synthesis of 2,5-Disubstituted 1,3,4-Oxadiazoles from Arylacetic Acids and Hydrazides via Dual Oxidation.

Authors:  Chinnari Lekkala; Varaprasad Bodala; Kumari Yettula; Bharat Kumar Karasala; Rajitha Lakshmi Podugu; Siddaiah Vidavalur
Journal:  ACS Omega       Date:  2022-07-27

6.  Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors.

Authors:  Sunil Kumar; Samir Mehndiratta; Kunal Nepali; Manish K Gupta; Surrinder Koul; Parduman R Sharma; Ajit K Saxena; Kanaya L Dhar
Journal:  Org Med Chem Lett       Date:  2013-03-03

Review 7.  Synthetic approaches and pharmacological activity of 1,3,4-oxadiazoles: a review of the literature from 2000-2012.

Authors:  Cledualdo Soares de Oliveira; Bruno Freitas Lira; José Maria Barbosa-Filho; Jorge Gonçalo Fernandez Lorenzo; Petrônio Filgueiras de Athayde-Filho
Journal:  Molecules       Date:  2012-08-27       Impact factor: 4.411

8.  Synthesis, cytotoxic evaluation, and molecular docking studies of some new 1, 3, 4-oxadiazole-based compounds.

Authors:  Farshid Hassanzadeh; Elham Jafari; Mohammadreza Zarabi; Ghadamali Khodarahmi; Golnaz Vaseghi
Journal:  Res Pharm Sci       Date:  2020-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.